Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 184. Immunodeficiency Disorders
Topics: Introduction | X-Linked Agammaglobulinemia | Selective Antibody Deficiency | Common Variable Immunodeficiency | Transient Hypogammaglobulinemia of Infancy | Chronic Mucocutaneous Candidiasis | DiGeorge Anomaly | Ataxia-Telangiectasia | Severe Combined Immunodeficiency Disease | Wiskott-Aldrich Syndrome | Hyperimmunoglobulinemia E Syndrome | Chronic Granulomatous Disease | Immunodeficiency due to Spleen Disorders
 
green line

Transient Hypogammaglobulinemia of Infancy

Transient hypogammaglobulinemia of infancy is an immunodeficiency disorder in which antibody production by an infant is delayed.

At birth, the immune system is not fully developed. Most of the antibodies in infants are those produced by the mother and transferred via the placenta before birth. Antibodies from the mother protect infants against infection until infants start to produce their own antibodies, usually by age 6 months. Infants who have transient hypogammaglobulinemia of infancy do not start producing antibodies until later. As a result, antibody levels become low starting at age 3 to 6 months and return to normal at about age 12 to 36 months. This disorder is more common among premature infants, because they receive fewer antibodies from the mother. Although the disorder is present at birth, it is not hereditary.

Most infants with the disorder have some antibodies. Therefore, they do not have a problem with infections and need no treatment. However, some infants, particularly those born prematurely, develop infections frequently. Immune globulin can prevent and help treat infections. It is usually given for about 6 to 12 months. Antibiotics are given when needed. Lifespan is unaffected.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.